Last updated: March 25, 2022
Sponsor: Li-jun Ding
Overall Status: Active - Recruiting
Phase
N/A
Condition
Perimenopause
Treatment
N/AClinical Study ID
NCT05308342
SZ-POF-2019-4
Ages 20-39 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Those who meet the POF diagnostic criteria and have no spontaneous follicularactivity;
- Married, 20 years old ≤ age < 40 years old;
- The average diameter of each ovary is > 10 mm;
- Have agreed to sign the informed consent form.
Exclusion
Exclusion Criteria:
- Female and/or male chromosomal abnormalities;
- Endometriosis, adenomyosis;
- Postoperative ovarian borderline or malignant tumor;
- Uterine dysplasia;
- Associated with female autoimmune disease or other serious internal surgical diseases;
- hormone replacement contraindications;
- In the past 1 year, had received an experimental study of premature ovarian failure inthe external hospital;
- Male azoospermia or severe oligozoospermia.
Study Design
Total Participants: 66
Study Start date:
November 20, 2019
Estimated Completion Date:
December 01, 2023
Study Description
Connect with a study center
Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
Nanjing, Jiangsu 210008
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.